Your session is about to expire
← Back to Search
Electrical Stimulation
BreEStim for Stroke
N/A
Waitlist Available
Led By Sheng Li, MD, PhD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Has post stroke ≥ 6 months, medically stable
Unilateral, single stroke (no restriction on type or volume of stroke)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 5 minutes after intervention
Awards & highlights
Study Summary
This trial will investigate whether a new intervention, Breathing-controlled electrical stimulation (BreEStim), can reduce spasticity in the fingers and improve hand function in people who have had a stroke.
Who is the study for?
This trial is for individuals who have had a stroke at least 6 months ago, are medically stable, and experience detectable muscle tightness in their fingers. It's not suitable for those adjusting to muscle relaxant medications, with pacemakers, recent toxin injections in the arm/fingers, pregnant women, or those with visual/hearing/cognitive impairments or pulmonary diseases.Check my eligibility
What is being tested?
The study tests Breathing-controlled electrical stimulation (BreEStim) to see if it helps reduce hand spasticity and improve hand function in people with severe impairment after a stroke. Participants will receive this novel intervention and its effects on motor recovery will be evaluated.See study design
What are the potential side effects?
Potential side effects of BreEStim may include discomfort at the site of stimulation, skin irritation from electrode placement, fatigue due to therapy sessions or unexpected reactions like increased spasticity; however specific side effects will be monitored throughout the trial.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I had a stroke more than 6 months ago and am now medically stable.
Select...
I have had one stroke.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 5 minutes after intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 5 minutes after intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in finger flexor spasticity measured by Modified Ashworth Scale (MAS)
Secondary outcome measures
Change in finger extensors and hand function measured by Fugl Myer Assessment (FMA) Scale
Trial Design
2Treatment groups
Experimental Treatment
Group I: EStimExperimental Treatment1 Intervention
EStim is transcutaneous electrical nerve stimulation.
Group II: BreEStimExperimental Treatment1 Intervention
BreEStim is voluntary breathing controlled transcutaneous electrical nerve stimulation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BreEStim
2015
N/A
~20
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
914 Previous Clinical Trials
324,368 Total Patients Enrolled
3 Trials studying Motor Recovery
22 Patients Enrolled for Motor Recovery
Sheng Li, MD, PhD4.896 ReviewsPrincipal Investigator - University of Texas
Swedish Medical Center / First Hill Campus, Swedish Medical Center / Cherry Hill Campus, Swedish Medical Center / Issaquah Campus
Medical School - Rosalind Franklin University of Medicine and Science, Doctor of Medicine
Louisiana State University, Residency in Ophthalmology
8 Previous Clinical Trials
97 Total Patients Enrolled
2 Trials studying Motor Recovery
8 Patients Enrolled for Motor Recovery
4Patient Review
The doctor and his team were thorough in their examination of my eyes. I left feeling satisfied.
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I haven't changed my muscle relaxant medications or had certain injections in my arm/fingers recently.I have issues with my vision, hearing, or thinking clearly.I had a stroke more than 6 months ago and am now medically stable.I have a history of lung problems like asthma or COPD.I have had one stroke.
Research Study Groups:
This trial has the following groups:- Group 1: EStim
- Group 2: BreEStim
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger